ReddyPort Inc’s ReddyPort Elbow received a CE Mark, which allows the company to market the device across the European Union and other CE Mark geographies.
ReddyPort features a proprietary elbow with self-sealing valve that provides access to the patient’s mouth. ReddyPort Elbow, in combination with ReddyPort NIV Maintenance Kit, allows the ability to clean and moisturize the patient’s mouth without mask removal. Oral hygiene is proven to help reduce risk of infection and improve patient satisfaction.
“CE Mark is an important milestone and validation of our vision to make ReddyPort the standard of care for patients on NIV,” said Scott Bostick, chief executive officer of ReddyPort. CE Mark approval means we can help patients in Europe who struggle tolerating NIV therapy due to known issues while wearing the mask; dry-mouth, phlegm build-up, and difficulty communicating. ReddyPort Elbow and oral care products help improve tolerance, patient compliance, and comfort, leading to more successful NIV. Supporting a successful NIV is especially important now as clinicians need it most during the COVID-19 pandemic.”
NIV is the first line of therapy in respiratory insufficiency or failure, commonly seen with COPD, CHF, asthma, pneumonia or ARDS1. NIV intolerance can lead to failure and escalation of care with mechanical ventilation. ReddyPort products promote NIV success, by empowering clinicians and patients with simplified oral access without interrupting patient therapy.
Source: ReddyPort
Image: ReddyPort 541-L1 Elbow; photo credit: ReddyPort, Inc. via prnewswire
Reference
1 Rochwerg B, Brochard L, Elliott MW, Hess D, et al. Official ERS/ATS Clinical Practice Guidelines: Noninvasive Ventilation for Acute Respiratory Failure. Eur Respir J. 2017: 31;50(2):1602426.